Akero Therapeutics (AKRO) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts AKRO Hot Sheet
Join SI Premium – FREE
Akero Therapeutics (NASDAQ: AKRO) reported Q2 EPS of ($0.81), $0.02 better than the analyst estimate of ($0.83).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Stifel Canada Starts BlackBerry (BB) at Buy
- JPMorgan Downgrades HCL Technologies (HCLT:IN) to Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
